XXII
22nd Century Group, Inc.
There isn't enough reported data to score XXII yet.
XXII Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Under pressure | |
| Unavailable |
XXII's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
XXII PE Valuation
XXII has no meaningful PE right now: it lost money over the past year.
XXII Forward outlook
There aren't enough analyst estimates for XXII to show an outlook.
XXII Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2023 | -$6,293,082,986.17 | -$3,440,457,386.17 |
| Q3 2023 | -$5,904,070,560.00 | -$2,532,785,760.00 |
| Q2 2023 | -$3,673,836,000.00 | -$302,551,200.00 |
| Q1 2023 | -$3,241,620,000.00 | -$259,329,600.00 |
| Q4 2022 | -$2,852,625,600.00 | -$129,664,800.00 |
| Q3 2022 | -$3,371,284,800.00 | -$1,296,648,000.00 |
| Q2 2022 | -$3,371,284,800.00 | -$1,685,642,400.00 |
| Q1 2022 | -$2,982,290,400.00 | -$1,166,983,200.00 |
XXII lost $6,293,082,986.17 per share over the past year, and its loss has widened in each of the last four quarters.
XXII Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.9M | -30% |
| Q1 2026 | $4.1M | -31% |
| Q4 2025 | $3.5M | -12% |
| Q3 2025 | $4M | -33% |
| Q2 2025 | $4.1M | -49% |
| Q1 2025 | $6M | -7.9% |
| Q4 2024 | $4M | -45% |
| Q3 2024 | $5.9M | -67% |
XXII's revenue has slid since its 2023 peak: $3M last quarter, down 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -115% | -42 points |
| Q1 2026 | -74% | -31 points |
| Q4 2025 | -79% | +23 points |
| Q3 2025 | -80% | -23 points |
| Q2 2025 | -73% | -47 points |
| Q1 2025 | -43% | +25 points |
| Q4 2024 | -102% | -968 points |
| Q3 2024 | -57% | +345 points |
XXII's operating margin was −115% last quarter, down 42 points from the same quarter a year ago.
XXII Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$4.3M | -$813K |
| Q1 2026 | -$3.1M | -$157K |
| Q4 2025 | $2.7M | +$7.1M |
| Q3 2025 | -$4M | -$977K |
| Q2 2025 | -$3.5M | +$1.3M |
| Q1 2025 | -$3M | -$724K |
| Q4 2024 | -$4.4M | +$1.1M |
| Q3 2024 | -$3M | +$11M |
XXII has burned cash in almost every quarter: −$9M over the past year, against −$14M the year before.
XXII Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +250% | +10 shares |
XXII Net Leverage
XXII's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
XXII Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 23.5 | Oversold |
| Stochastic | 0.0 | Oversold |
XXII's weekly RSI is 24 (oversold) and its Stochastic is 0 (oversold).
XXII PE vs Consumer Defensive Sector
XXII has no meaningful PE right now: it lost money over the past year.
XXII Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.9 | 95% below |
| 20 week MA | $134.2 | 99% below |
| 50 week MA | $3,909.0 | 100% below |
| 100 week MA | $265,401.1 | 100% below |
| 200 week MA | $1,346,419,789.7 | 100% below |
XXII is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
XXII Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14,781,787,200.0 | $29,693,239,200.0 | +101% |
| 2021 | $29,693,239,200.0 | $39,547,764,000.0 | +33% |
| 2022 | $39,547,764,000.0 | $11,464,961,616.0 | -71% |
| 2023 | $11,464,961,616.0 | $160,957,238.4 | -99% |
| 2024 | $160,957,238.4 | $1,996,998.0 | -99% |
| 2025 | $1,996,998.0 | $15,221.5 | -99% |
| 2026 YTD | $15,221.5 | $1.30 | -100% |
XXII has finished four years in a row lower, and it's down 100% so far in 2026.